Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tacrolimus: focusing on atopic dermatitis.

Christie L Carroll1, Alan B Fleischer

  • 1Department of Dermatology, Wake Forest University School of Medicine, Winston-Salem, North Carolina 27157-1071, USA.

Drugs of Today (Barcelona, Spain : 1998)
|August 9, 2006
PubMed
Summary

Tacrolimus ointment effectively treats atopic dermatitis by inhibiting calcineurin, offering a safe profile with minimal systemic absorption. Clinical trials show it is more effective than pimecrolimus and comparable or superior to topical corticosteroids.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Time to Meaningful Clinical Response Across Approved and Emerging Therapies for Antihistamine-Refractory Chronic Spontaneous Urticaria: A Network Meta-Analysis.

Journal of clinical medicine·2026
Same author

Response to commentary: Aligning dermatology continuing certification and quality outcomes through research.

Journal of the American Academy of Dermatology·2026
Same author

Retirement Patterns in Mohs Micrographic Surgeons and General Dermatologists: A Medicare Part B and Part D Analysis.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]·2026
Same author

Mandatory recertification and practice patterns of dermatologists: A Medicare Part B and Part D Database analysis.

Journal of the American Academy of Dermatology·2026
Same author

Reply to Torres et al, "Reply to Woodie et al, 'Elevated risk of active tuberculosis with interleukin-17, interleukin-23, interleukin-12/23, Janus kinase inhibitors, cyclosporine, and tumor necrosis factor-α inhibitors compared with the general population: A population-based analysis using TriNetX'".

Journal of the American Academy of Dermatology·2026
Same author

Modifiable Factors Such as Nicotine Use, Obesity, Vitamin D Deficiency, Diabetes, and Hypertension Predict Acute Complications of Dermatologic Surgery.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]·2026

Area of Science:

  • Immunology
  • Dermatology
  • Pharmacology

Background:

  • Atopic dermatitis is a chronic inflammatory skin condition.
  • Current treatments include topical corticosteroids, which can have side effects.
  • Novel therapeutic options are needed for effective and safe management.

Purpose of the Study:

  • To evaluate the efficacy and safety of tacrolimus ointment for atopic dermatitis.
  • To compare tacrolimus ointment with pimecrolimus and topical corticosteroids.

Main Methods:

  • Review of clinical trials comparing tacrolimus ointment to other treatments.
  • Analysis of tacrolimus's mechanism of action as a calcineurin inhibitor.
  • Assessment of systemic absorption and safety profile.

Related Experiment Videos

Main Results:

  • Tacrolimus ointment demonstrated superior efficacy compared to pimecrolimus in head-to-head trials.
  • Tacrolimus ointment showed comparable or superior effectiveness to several topical corticosteroids.
  • Minimal systemic absorption was observed, indicating a favorable safety profile.

Conclusions:

  • Tacrolimus ointment is a safe and effective treatment for atopic dermatitis.
  • It can be used as a primary or adjunctive therapy alongside topical corticosteroids.
  • Its mechanism involves inhibiting calcineurin and NFAT dephosphorylation, crucial in T-cell activation.